Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer
Frontiers in Cell and Developmental Biology · 25.06.2025 · 13
DOI: 10.3389/fcell.2025.1646699 ↗Kurz gefasst
Korrektur in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 25.06.2025. Verfasst von Jinpeng Cen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Urology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
- Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Radiotherapy, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
- Department of Urology, The Fourth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
- First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, China.
Zitieren
APA
Cen, J., Guo, J., Zeng, X., Song, X., Ge, S., Chen, M., Li, Q., Yu, Y., Lv, D., & Zhao, S. (2025). Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1646699
Vancouver
Cen J, Guo J, Zeng X, Song X, Ge S, Chen M, et al. Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1646699
BibTeX
@article{Cen2025,
author = {Cen, Jinpeng and Guo, Jiading and Zeng, Xianzi and Song, Xianlu and Ge, Shengdong and Chen, Mingkun and Li, Qianyi and Yu, Yuzhong and Lv, Daojun and Zhao, Shanchao},
title = {Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1646699}
}
EUVIMED